non-peptide non - sequence-of-amino-acids-in-a-peptide-chain non-peptidomimetic glucagon-like peptide-1 receptor agonists

non-ribosomal-peptide-synthetases The term "non-peptide" refers to molecules that are not composed of amino acids linked by peptide bonds, differentiating them from peptides and proteins. This distinction is particularly significant in pharmacology and biochemistry, where non-peptide compounds are being developed as alternatives to peptide-based drugsNon-Peptide Agonists and Positive Allosteric Modulators of .... The development of non-peptide GLP-1 receptor agonists, for instance, represents a major advancement, offering potential advantages such as oral bioavailability and improved stability compared to their peptide counterparts. These small-molecule agonists are being investigated for their efficacy in treating conditions like type 2 diabetes and obesityNon-Peptide Gonadotropin-Releasing Hormone Receptor ....

Non-Peptide Drugs and Their Therapeutic Potential

The exploration of non-peptide molecules has opened new avenues in drug development, especially in targeting receptors traditionally activated by peptides作者：RM Freidinger·1989·被引用次数：118—Considerable progress has been made insynthesizing peptide analogswith improved stability for probing function of peptide-receptor systems.. A key area of research involves non-peptide GLP-1 receptor agonists. Glucagon-like peptide-1 (GLP-1) is a crucial hormone involved in regulating glucose homeostasis and appetite. While GLP-1 itself is a peptide, the development of non-peptide agonists that can mimic or modulate its effects offers significant therapeutic promise. These non-peptide compounds, often referred to as small molecules, can bind to the GLP-1 receptor, initiating similar signaling pathways to native GLP-1.

One notable example is the development of non-peptide GLP-1 receptor agonists that can be administered orally. Unlike peptide drugs, which are often degraded in the digestive system and require injection, orally available non-peptide drugs can offer greater convenience and patient adherence. Compounds like Orforglipron have shown efficacy in reducing glucose levels and body weight, positioning them as potential treatments for type 2 diabetes and obesity.Non-peptide, once-per-day oral orforglipron to compete ... The ability of these non-peptide agonists to reduce glycated hemoglobin (HbA1c) and promote weight loss in clinical studies highlights their therapeutic value.

Advantages of Non-Peptide Ligands

The shift from peptide-based to non-peptide therapeutics is driven by several key advantages. Peptides, by their nature, are susceptible to enzymatic degradation, which can limit their half-life and efficacy in the body. Furthermore, their administration is often restricted to parenteral routes (e.g., injection) due to poor oral absorption. Non-peptide ligands, on the other hand, are typically small molecules with chemical structures that can be engineered for enhanced stability and oral bioavailability. This makes them attractive candidates for developing drugs that are easier to administer and may offer a more consistent therapeutic effect.

Beyond GLP-1 receptors, non-peptide ligands are also being explored for other peptide receptors. For example, research into non-peptide antagonists of gonadotropin-releasing hormone (GnRH) receptors has identified a new class of potential therapeutics for various conditions.作者：I Idris·2023·被引用次数：1—Efficacy of anon-peptide GLP-1 analogue, Orfogliptonto induce weight loss reported in a phase 2 study. While the availability of peptides targeting GLP-1 ... Similarly, the design of non-peptide agonists and antagonists for neuropeptide receptors is an ongoing area of investigation, aiming to leverage the benefits of small-molecule drugs for targets previously addressed only by peptides.

Nonribosomal Peptides and Other Distinctions

It is important to distinguish the broad category of "non-peptide" from specific molecular classes.作者：DC Horwell·1998·被引用次数：5—Design of non-peptide agonists and antagonists at neuropeptide receptorsstarting from the chemical structure of neuropeptides. Published: May 1998. Volume 5, ... For instance, nonribosomal peptides (NRPs) are a unique group of peptide secondary metabolites produced by microorganismsNonapeptide - an overview | ScienceDirect Topics. While they are peptides, their biosynthesis differs from the ribosomal synthesis of proteins and other peptidesFDA has warned companies that have illegally sold unapproved drugs containing semaglutide, tirzepatide or retatrutide that are falsely labeled “for research .... Understanding these distinctions is crucial in fields like natural product discovery and drug development.

The development of non-peptide mimetics, compounds that mimic the function of peptides, is a sophisticated area of medicinal chemistry. These efforts aim to capture the biological activity of a peptide while retaining the favorable pharmacokinetic properties of small molecules.Discovery of non-peptide GLP-1r natural agonists for ... The ongoing research into non-peptide GLP-1 receptor agonists and other non-peptide ligands underscores the significant progress in this field, paving the way for novel therapeutic strategies2025年8月9日—In a phase II study targeting patients with type 2 diabetes, Orforglipron demonstrated a significant reduction in glycated hemoglobin (HbA1c) ....